CTC-AE+

The adverse event logger

Published by: Arpacore

Description

CTC-AE+ has been fully redesigned and updated for the latest iPhone and iPad devices and operating systems, delivering an improved user experience and powerful new features.
CTC-AE+ offers quick and intuitive access to the Common Terminology Criteria for Adverse Events (CTCAE) lists (versions 4 and 5), essential in oncology for the standardization, monitoring, and reporting of adverse events (AEs). Each AE is clearly defined and presented with a severity grading scale, structured according to System Organ Classes (SOCs) as per the Medical Dictionary for Regulatory Activities (MedDRA).
### What's New
- **Completely rewritten:** Optimized for new devices and the latest iOS/iPadOS.
- **New Pediatric Score:** Inclusion of the Lansky Performance Score for pediatric patients.
- **Enhanced usability:** Improved navigation, streamlined AE logging, and enhanced performance scores integration.
### Core Features
- **Comprehensive AE Reference:** Browse and reference detailed definitions and grading scales for AE terms commonly encountered in oncology research.
- **Performance Scores Included:** Easily reference Karnofsky, ECOG, and now Lansky scores to evaluate patient conditions quickly and accurately.
- **Advanced AE Logger:** Record and track adverse events across multiple clinical studies, patients, and events.
- **Flexible Data Entry:** Select AEs from the comprehensive CTCAE databases (v4 and v5), performance score tables, or create custom events tailored to your clinical trials.
- **Enhanced Data Import/Export:** Import data from CSV files either by replacing existing data or merging with current records. Export AE records in multiple formats, with the option to exclude patient names from exported CSV files, ensuring privacy and compliance.
- **Efficient Patient Management:** Quickly access a comprehensive patient list covering all clinical studies. Easily toggle between ascending and descending sorting by tapping on the titles in the trial list, patient list, or adverse event list.
### Privacy and Compliance
- **EU GDPR Compliant:** All data remains strictly on-device, ensuring maximum privacy and regulatory compliance. No patient data or clinical information is ever uploaded to remote or cloud services.
CTC-AE+ remains your essential companion for standardized AE tracking, efficient patient monitoring, and precise clinical data reporting in oncology research.
Hide Show More...

In-Apps

Adverse Event Logger
149.00 ฿

Screenshots

CTC-AE+ FAQ

  • Is CTC-AE+ free?

    Yes, CTC-AE+ is free to download, however it contains in-app purchases or subscription offerings.

  • Is CTC-AE+ legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does CTC-AE+ cost?

    CTC-AE+ has several in-app purchases/subscriptions, the average in-app price is 149.00 ฿.

  • What is CTC-AE+ revenue?

    To get estimated revenue of CTC-AE+ app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Thailand yet.
Ratings History

CTC-AE+ Reviews

Un-complete

Ricardo Sanchez-Escribano on

Spain

Easy to use but the hematological toxicities chapter dont include thrombopenia or neutropenia this is a serious mistake please review and fix it the overall idea is good

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
Chart
Category
Rank
Top Paid
5
Top Paid
36
Top Paid
41
Top Grossing
48
Top Paid
77

CTC-AE+ Competitors

CTC-AE+ Installs

Last 30 days

CTC-AE+ Revenue

Last 30 days

CTC-AE+ Revenue and Downloads

Gain valuable insights into CTC-AE+ performance with our analytics.
Sign up now to access downloads, revenue, and more.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.